|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.190 HKD | +3.80% |
|
+9.49% | -16.02% |
| 07-10 | Sino Biopharma Unit Gets China Acceptance for Biliary Tract Cancer Drug | MT |
| 07-08 | European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites | MT |
| Market Cap | 80.03B 92.53B 11.8B 10.32B 9.52B 8.79B 16.69B 1,126B 16.97B 114B 44.68B 555B 44.32B 43.35B 1,906B | P/E 2026 * |
19.8x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 75.29B 87.06B 11.1B 9.71B 8.96B 8.27B 15.7B 1,059B 15.97B 107B 42.04B 522B 41.69B 40.79B 1,794B | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.78x |
| Free-Float |
49.12% | Yield 2026 * |
1.77% | Yield 2027 * | 1.91% |
| 1 day | +3.80% | ||
| 1 week | +9.49% | ||
| Current month | +17.69% | ||
| 1 month | +16.37% | ||
| 3 months | -12.33% | ||
| 6 months | -24.01% | ||
| Current year | -16.02% |
| 1 week | 4.7 |  | 5.35 |
| 1 month | 4.19 | | 5.35 |
| Current year | 4.19 | | 7.29 |
| 1 year | 4.19 | | 9.12 |
| 3 years | 2.29 | | 9.12 |
| 5 years | 2.29 | | 9.12 |
| 10 years | 2.17 | | 11.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
S Y Tse
CEO | Chief Executive Officer | 30 | 28/07/2022 |
Chun Ling Li
DFI | Director of Finance/CFO | 55 | 01/01/1996 |
Xiao yan Kang
CTO | Chief Tech/Sci/R&D Officer | - | 28/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Tse
CHM | Chairman | 74 | 02/02/2000 |
Hsin Tse
BRD | Director/Board Member | 56 | 01/08/1995 |
| Director/Board Member | 62 | 10/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-29 | Other | Founder | 2,000,000 | 0.0107% | ||
| 04-28 | Other | Founder | 3,000,000 | 0.0160% | ||
| 12-24 | Other | Director | 1,000,000 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.80% | +9.49% | -12.48% | +51.31% | 11.8B | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | |
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | |
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | |
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | |
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | |
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | |
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | |
| Average | -0.68% | -1.97% | +22.80% | +56.16% | 358.57B | |
| Weighted average by Cap. | -1.30% | -2.92% | +36.59% | +83.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.19B 41.84B 5.34B 4.67B 4.31B 3.98B 7.55B 509B 7.67B 51.45B 20.2B 251B 20.04B 19.6B 862B | 39.25B 45.38B 5.79B 5.06B 4.67B 4.31B 8.18B 552B 8.32B 55.8B 21.91B 272B 21.73B 21.26B 935B |
| Net income | 3.98B 4.61B 588M 514M 474M 438M 831M 56.04B 845M 5.66B 2.22B 27.61B 2.21B 2.16B 94.91B | 4.35B 5.03B 642M 562M 518M 479M 908M 61.25B 923M 6.19B 2.43B 30.17B 2.41B 2.36B 104B |
| Net Debt | -4.73B -5.47B -698M -611M -563M -520M -987M -66.59B -1B -6.73B -2.64B -32.81B -2.62B -2.56B -113B | -10.13B -11.72B -1.49B -1.31B -1.21B -1.11B -2.11B -143B -2.15B -14.4B -5.66B -70.21B -5.61B -5.49B -241B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | HK$5.190 | +3.80% | 177,337,052 |
| 09/07/26 | HK$5.000 | +3.73% | 146,854,294 |
| 08/07/26 | HK$4.820 | 0.00% | 188,359,835 |
| 07/07/26 | HK$4.820 | -4.55% | 88,072,287 |
| 06/07/26 | HK$5.050 | +6.54% | 249,396,352 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1177 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition